Location History:
- Baltimore, MD (US) (2015)
- Severna Park, MD (US) (2013 - 2016)
- Saverna Park, MD (US) (2018)
Company Filing History:
6 out of 3,688 
2 out of 3,539 
Years Active: 2013-2025
Title: Richard B S Roden: Innovator in Cancer Treatment and Vaccine Development
Introduction
Richard B S Roden is a prominent inventor based in Severna Park, MD (US). He has made significant contributions to the fields of cancer treatment and vaccine development, holding a total of 6 patents. His innovative work has the potential to impact public health positively.
Latest Patents
Among his latest patents, Roden has developed anti-cancer spirocyclic-guanidine compounds and their uses. This invention discloses spirocyclic guanidine compounds of general formula (I) and their application in methods of treating cancer. Additionally, he has worked on papillomavirus-like particles (VLP) as broad-spectrum human papillomavirus (HPV) vaccines. This invention relates to a VLP composition assembled from a chimeric polypeptide comprising a papillomavirus L1 major capsid protein, which includes a surface-displayed peptide with a neutralizing epitope of a papillomavirus L2 protein. The vaccine compositions comprising the VLP are designed to induce an immune response against papillomavirus.
Career Highlights
Roden has had a distinguished career, working with esteemed institutions such as The Johns Hopkins University and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these organizations has allowed him to contribute significantly to medical research and innovation.
Collaborations
Throughout his career, Roden has collaborated with notable colleagues, including Ratish Gambhira and Reinhard Kirnbauer. These collaborations have further enhanced his research and development efforts in the field of healthcare.
Conclusion
Richard B S Roden is a notable inventor whose work in cancer treatment and vaccine development has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his commitment to advancing medical science.